Terms: = Prostate cancer AND SETD2, ENSG00000181555, 29072
6 results:
1. SETting Up for Epigenetic Regulation of Advanced prostate cancer.
Thienger P; Rubin MA
Cancer Cell; 2020 Sep; 38(3):309-311. PubMed ID: 32931739
[TBL] [Abstract] [Full Text] [Related]
2. setd2 Restricts prostate cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.
Yuan H; Han Y; Wang X; Li N; Liu Q; Yin Y; Wang H; Pan L; Li L; Song K; Qiu T; Pan Q; Chen Q; Zhang G; Zang Y; Tan M; Zhang J; Li Q; Wang X; Jiang J; Qin J
Cancer Cell; 2020 Sep; 38(3):350-365.e7. PubMed ID: 32619406
[TBL] [Abstract] [Full Text] [Related]
3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
4.
Kim SH; Park WS; Chung J
Investig Clin Urol; 2019 May; 60(3):148-155. PubMed ID: 31098421
[TBL] [Abstract] [Full Text] [Related]
5. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in prostate cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract] [Full Text] [Related]
6. Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
Tennenbaum DM; Manley BJ; Zabor E; Becerra MF; Carlo MI; Casuscelli J; Redzematovic A; Khan N; Arcila ME; Voss MH; Feldman DR; Motzer RJ; Benfante NE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
Urol Oncol; 2017 Aug; 35(8):532.e7-532.e13. PubMed ID: 28408295
[TBL] [Abstract] [Full Text] [Related]
